Chemotherapy Toxicity Considerations in Soft Tissue Sarcoma
0 Mga view
• 07/18/23
0
0
I-embed
administrator
Mga subscriber
The panelists, Brian Van Tine, MD, PhD; Robin Jones, MD, MRCP; Andrew Wagner, MD, PhD; Lor Randall, MD, FACS; Shreyaskumar Patel, MD; and Jonathan Trent, MD, PhD; discuss the factors they consider when balancing the risks and benefits of chemotherapy treatment in soft tissue sarcoma.
Magpakita ng higit pa
Mga Komento sa Facebook
SORT BY-
Mga Nangungunang Komento
-
Pinakabagong komento